Kevin Doody
Reproductive Endocrinology · Bedford, TXNPI 1568429975
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $72,434 of the $118,401 with a category attached, or 61.2%. 11 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 56.9% of the total. Reporting peaked in 2019 at $53,155 and has fallen 96.3% since, to $1,966 in 2025. Among reproductive endocrinology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $503.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$67K
- Ferring Pharmaceuticals Pty Ltd$26K
- Ferring Pharmaceuticals (asia) Co. Ltd.$7K
- Ferring Pharmaceuticals Private Ltd$7K
- Organon$5K
- EMD Serono, Inc.$2K
- plus $4K from 5 others
Across 126 payments — averaging $20,922 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring International Pharmascience Center US$2.2M
- IBSA Institut Biochimique SA$425K
- Siemens Medical Solutions USA, Inc.$25K
- Gilead$21K
- Merck$0
What the payments were for
- Consulting fees$72,43461%
- Speaking & faculty fees$20,26017%
- Travel & lodging$20,37917%
- Food & beverage$5,3184%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 182 | $67,371 |
| Ferring Pharmaceuticals Pty Ltd | 16 | $25,547 |
| Ferring Pharmaceuticals (asia) Co. Ltd. | 1 | $7,464 |
| Ferring Pharmaceuticals Private Ltd | 2 | $6,600 |
| Organon | 13 | $4,988 |
| EMD Serono, Inc. | 6 | $2,144 |
| Ferring International Center SA | 1 | $1,548 |
| Granata Bio Corporation | 3 | $1,409 |
| Merck | 2 | $759 |
| Coopersurgical, Inc. | 8 | $553 |
| Minerva Surgical, Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MENOPUR$50,435
- INVOCELL$37,585
- ENDOMETRIN$1,290
- ORIGIO Sequential Fert$144
- STRIPPER$139
- BRAVELLE$113
How this compares
$118,401 in reported general payments places this provider in the 95th percentile of 142 reproductive endocrinology providers in Texas.
Other reproductive endocrinology in Bedford
- Kathleen DoodyBedford$49K
- Kaitlin DoodyBedford$2K
- Kimberly YauBedford$1K
- Randall DunnHouston$234K
- Jason GriffithSpring$145K
- Kaylen SilverbergAustin$127K
- Matthew RetzloffSan Antonio$120K
- Robert KauffmanAmarillo$46K
- Satin PatelDallas$32K
- Craig WitzHouston$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.